There are about 10–20% advanced PCA patients harbored alterations in the WNT signaling pathway, including inactivating mutations in APC and RNF43, and activating mutations in CTNNB1 and RSPO2 [13, 16]. Here, RNF43 is linked to posterior cortical atrophy.